The biggest Alzheimer’s study ever finds new genes and pathways involved in disease progression.
CREDIT: GETTY IMAGES
The groundbreaking study’s findings imply physicians can better anticipate whether a patient is genetically prone to Alzheimer’s. Alzheimer’s disease affects over 5.8 million Americans. Researchers from France’s Université de Lille performed the study. A genetic risk score may help determine who is most likely to develop Alzheimer’s.
To better understand Alzheimer’s and create medicines that delay or prevent the disease start, the research represents a huge step forward. The next stage is for researchers to concentrate on the study’s risk genes and their influence in brain cell malfunction and death.